Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Gilead’s pill shows promise in HIV prevention

November 25, 2010 Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir

Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
News

UN says Treatment 2.0 approach needed for AIDS

November 25, 2010 Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS

A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …
News

Roche set to challenge NICE Tarceva decision

November 25, 2010 Sales and Marketing NICE, Roche, Roche UK, Tarceva, erlotinib, lung cancer

NICE has again rejected Roche’s lung cancer drug Tarceva in its second round of draft guidance. Tarceva (erlotinib) was being …
News

The renal cell carcinoma market: Votrient to challenge Sutent’s lead

November 25, 2010 Sales and Marketing GSK, GlaxoSmithKline, Pfizer, Sutent, Votrient, rcc, renal cell carcinoma

After decades of no new medicines emerging to treat renal cell carcinoma, no fewer than five new drugs were approved …
Feature

GSK sells antibiotics assets to Dr Reddy’s

November 24, 2010 Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK

Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …
News

Brain cancer vaccine to move into phase III

November 24, 2010 Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma

Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …
News

NICE recommends Herceptin for gastric cancer, blocks high dose Glivec

November 24, 2010 Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer

NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …
News

Brinsmead to be life sciences adviser to government

November 23, 2010 Sales and Marketing Brinsmead, NHS, government, life sciences

Chris Brinsmead, chairman of AstraZeneca UK, has been made the government’s life sciences business adviser. He was appointed by universities …
News

Roche to develop diagnostic tools for Tarceva

November 23, 2010 Sales and Marketing Genzyme, NSCLC, Roche, Tarceva, diagnostic

Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …
News

Vytorin cuts heart problems in kidney patients

November 23, 2010 Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin

Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
News

Offshore outsourcing in Regulatory Affairs and Pharmacovigilance

November 22, 2010 Sales and Marketing Kinapse, White paper

Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …
Feature
White paper

A new generation of analogues for valuing strategy

November 22, 2010 Sales and Marketing Alex Blyth, MSI, forecasting, marketing, marketing strategy

Anyone who is involved in the planning of pharma marketing campaigns will know that the Holy Grail is trying to …
Feature

Chris King joins Synovate Healthcare

November 22, 2010 Sales and Marketing Chris King, Synovate Healthcare, appointment, sales and marketing

Synovate has appointed Chris King head of its European Oncology Monitor within its specialist healthcare research division. He joins the …
Appointment

Bayer’s challenger to Lucentis shows promise

November 22, 2010 Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
News

Daiichi-Sankyo cleared of rep misconduct

November 22, 2010 Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative

Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026